Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 733

Results For "CE"

8101 News Found

Yashoda Hospitals, Hyderabad saves five-year-old with timely kidney surgery
Hospitals | December 08, 2021

Yashoda Hospitals, Hyderabad saves five-year-old with timely kidney surgery

Approximately five kg tumor was removed in the eight-hour long complicated surgery


Redcliffe Labs chalks out aggressive expansion plans
Diagnostic Center | December 08, 2021

Redcliffe Labs chalks out aggressive expansion plans

It plans to add over 1000 employees over the next six months


Olympus lays out its plans for growth in the medical business
Digitisation | December 08, 2021

Olympus lays out its plans for growth in the medical business

Investment in single-use endoscopes, digital solutions, and endoluminal therapies expected


Cadila Pharma launches ayurvedic energy tonic Healtherbs
Healthcare | December 08, 2021

Cadila Pharma launches ayurvedic energy tonic Healtherbs

Healtherbs helps in restoring the desired energy levels for daily activity and immunity


IPM registers 6 % yoy revenue growth in Nov 2021.
News | December 08, 2021

IPM registers 6 % yoy revenue growth in Nov 2021.

Ind-Ra expects IPM revenue growth of over 12% yoy for FY22.


Fujifilm collaborates with DCC Animal hospital for diagnostics support
Diagnostic Center | December 07, 2021

Fujifilm collaborates with DCC Animal hospital for diagnostics support

Fujifilm India will be providing healthcare Imaging devices and equipment’s to increase the standards of the veterinary care in India.


Study shows Glaxo-Vir drug works against Omicron mutations
News | December 07, 2021

Study shows Glaxo-Vir drug works against Omicron mutations

Data builds on promising signal published last week, underscoring the importance of sotrovimab for early treatment of COVID-19


Hilleman Laboratories invests US $ 58 mn to establish vaccine hub in Singapore
Biotech | December 07, 2021

Hilleman Laboratories invests US $ 58 mn to establish vaccine hub in Singapore

The facility will supply clinical trial materials for the development of vaccines and biologics up to Phase II stage and is expected to be fully operational by early 2023.


Roche develops tests to identify Omicron variant
Medical Device | December 06, 2021

Roche develops tests to identify Omicron variant

Roche subsidiary TIB Molbiol rapidly developed additional testing options to differentiate mutations in the Omicron SARS-CoV-2 variant, as they continue to offer new and accurate detection solutions


Lilly's bamlanivimab with etesevimab authorized for emergency use in Covid-19 patients under 12
Drug Approval | December 06, 2021

Lilly's bamlanivimab with etesevimab authorized for emergency use in Covid-19 patients under 12

Expanded EUA includes both treatment of patients with Covid-19 and post-exposure prophylaxis (PEP) in high-risk pediatric and infant patients